Literature DB >> 19442118

Potential usage of ING family members in cancer diagnostics and molecular therapy.

Mehmet Gunduz1, Kadir Demircan, Esra Gunduz, Naoki Katase, Ryo Tamamura, Hitoshi Nagatsuka.   

Abstract

The Inhibitor of Growth (ING) gene family is an emerging putative type II tumor suppressor gene (TSG). Proteins of INGs (ING1-5), critical modulator of the histone code via PHD fingers, are able to suppress cell growth and proliferation, induce apoptosis, and modulate cell cycle progression. ING proteins are involved in transcriptional regulation of genes, such as the p53-inducible gene p21. ING proteins also serve as shuttling proteins between nucleus and cytoplasm, and dysregulation of this nucleocytoplasmic traffic has been shown in some cancer cells. In cancer cells, ING mRNA levels are often lost or suppressed but the genes are rarely mutated. Recently the potential roles of ING proteins as prognostic biomarkers, detection of aggressive behavior of the tumor as well as prediction of chemo-radiotherapy response have also emerged. In this review, we summarize the up-to-date knowledge on functions of the ING proteins, the protein status in human tumors and discuss as a potential target in the molecular diagnostics and therapy of cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19442118     DOI: 10.2174/138945009788185086

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  9 in total

Review 1.  LincRNa-p21: function and mechanism in cancer.

Authors:  Shaoyun Chen; Hairong Liang; Hui Yang; Kairu Zhou; Longmei Xu; Jiaxian Liu; Bei Lai; Li Song; Hao Luo; Jianming Peng; Zhidong Liu; Yongmei Xiao; Wen Chen; Huanwen Tang
Journal:  Med Oncol       Date:  2017-04-19       Impact factor: 3.064

2.  The expression of p33(ING1), p53, and autophagy-related gene Beclin1 in patients with non-small cell lung cancer.

Authors:  Jun Liu; Yongping Lin; Haihong Yang; Qiuhua Deng; Guoqin Chen; Jianxing He
Journal:  Tumour Biol       Date:  2011-07-22

3.  Down-regulation of miR-622 in gastric cancer promotes cellular invasion and tumor metastasis by targeting ING1 gene.

Authors:  Xiao-Bo Guo; Chang-Qing Jing; Le-Ping Li; Li Zhang; Yu-Long Shi; Jin-Shen Wang; Jing-Lei Liu; Chen-Sheng Li
Journal:  World J Gastroenterol       Date:  2011-04-14       Impact factor: 5.742

4.  p33ING1b regulates acetylation of p53 in oral squamous cell carcinoma via SIR2.

Authors:  Xiao-Han Li; Dan Li; Chang Liu; Ming-Ming Zhang; Xiao-Jiao Guan; Ya-Ping Fu
Journal:  Cancer Cell Int       Date:  2020-08-18       Impact factor: 5.722

5.  Modulation of thyroid hormone-dependent gene expression in Xenopus laevis by INhibitor of Growth (ING) proteins.

Authors:  Caren C Helbing; Mary J Wagner; Katherine Pettem; Jill Johnston; Rachel A Heimeier; Nik Veldhoen; Frank R Jirik; Yun-Bo Shi; Leon W Browder
Journal:  PLoS One       Date:  2011-12-05       Impact factor: 3.240

6.  LincRNA-p21 acts as a mediator of ING1b-induced apoptosis.

Authors:  U M Tran; U Rajarajacholan; J Soh; T-s Kim; S Thalappilly; C W Sensen; K Riabowol
Journal:  Cell Death Dis       Date:  2015-03-05       Impact factor: 8.469

Review 7.  Epigenetics in oral squamous cell carcinoma.

Authors:  K N Hema; T Smitha; H S Sheethal; S Angeline Mirnalini
Journal:  J Oral Maxillofac Pathol       Date:  2017 May-Aug

8.  Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.

Authors:  Yong-Wan Kim; Eun Young Kim; Doin Jeon; Juinn-Lin Liu; Helena Suhyun Kim; Jin Woo Choi; Woong Shick Ahn
Journal:  Drug Des Devel Ther       Date:  2014-02-24       Impact factor: 4.162

9.  Tumor cell apoptosis mediated by cytoplasmic ING1 is associated with improved survival in oral squamous cell carcinoma patients.

Authors:  Pinaki Bose; Satbir S Thakur; Nigel T Brockton; Alexander C Klimowicz; Elizabeth Kornaga; Steven C Nakoneshny; Karl T Riabowol; Joseph C Dort
Journal:  Oncotarget       Date:  2014-05-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.